Elanco Animal Health Inc - 8-K Filing

Elanco Animal Health reports Q3 2026 revenue of $1.265B and raises full-year guidance following strong organic growth. (Items: 2.02 Results of Operations or Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $ELAN

Read the full article at SEC EDGAR

Part of the story PG&E Corp - 8-K Filing (47 articles)

More Regulatory news